Cargando…

CFTR and Ca(2+) Signaling in Cystic Fibrosis

Among the diverse physiological functions exerted by calcium signaling in living cells, its role in the regulation of protein biogenesis and trafficking remains incompletely understood. In cystic fibrosis (CF) disease the most common CF transmembrane conductance regulator (CFTR) mutation, F508del-CF...

Descripción completa

Detalles Bibliográficos
Autores principales: Antigny, Fabrice, Norez, Caroline, Becq, Frédéric, Vandebrouck, Clarisse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3200540/
https://www.ncbi.nlm.nih.gov/pubmed/22046162
http://dx.doi.org/10.3389/fphar.2011.00067
_version_ 1782214700626345984
author Antigny, Fabrice
Norez, Caroline
Becq, Frédéric
Vandebrouck, Clarisse
author_facet Antigny, Fabrice
Norez, Caroline
Becq, Frédéric
Vandebrouck, Clarisse
author_sort Antigny, Fabrice
collection PubMed
description Among the diverse physiological functions exerted by calcium signaling in living cells, its role in the regulation of protein biogenesis and trafficking remains incompletely understood. In cystic fibrosis (CF) disease the most common CF transmembrane conductance regulator (CFTR) mutation, F508del-CFTR generates a misprocessed protein that is abnormally retained in the endoplasmic reticulum (ER) compartment, rapidly degraded by the ubiquitin/proteasome pathway and hence absent at the plasma membrane of CF epithelial cells. Recent studies have demonstrated that intracellular calcium signals consequent to activation of apical G-protein-coupled receptors by different agonists are increased in CF airway epithelia. Moreover, the regulation of various intracellular calcium storage compartments, such as ER is also abnormal in CF cells. Although the molecular mechanism at the origin of this increase remains puzzling in epithelial cells, the F508del-CFTR mutation is proposed to be the onset of abnormal Ca(2+) influx linking the calcium signaling to CFTR pathobiology. This article reviews the relationships between CFTR and calcium signaling in the context of the genetic disease CF.
format Online
Article
Text
id pubmed-3200540
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Frontiers Research Foundation
record_format MEDLINE/PubMed
spelling pubmed-32005402011-11-01 CFTR and Ca(2+) Signaling in Cystic Fibrosis Antigny, Fabrice Norez, Caroline Becq, Frédéric Vandebrouck, Clarisse Front Pharmacol Pharmacology Among the diverse physiological functions exerted by calcium signaling in living cells, its role in the regulation of protein biogenesis and trafficking remains incompletely understood. In cystic fibrosis (CF) disease the most common CF transmembrane conductance regulator (CFTR) mutation, F508del-CFTR generates a misprocessed protein that is abnormally retained in the endoplasmic reticulum (ER) compartment, rapidly degraded by the ubiquitin/proteasome pathway and hence absent at the plasma membrane of CF epithelial cells. Recent studies have demonstrated that intracellular calcium signals consequent to activation of apical G-protein-coupled receptors by different agonists are increased in CF airway epithelia. Moreover, the regulation of various intracellular calcium storage compartments, such as ER is also abnormal in CF cells. Although the molecular mechanism at the origin of this increase remains puzzling in epithelial cells, the F508del-CFTR mutation is proposed to be the onset of abnormal Ca(2+) influx linking the calcium signaling to CFTR pathobiology. This article reviews the relationships between CFTR and calcium signaling in the context of the genetic disease CF. Frontiers Research Foundation 2011-10-25 /pmc/articles/PMC3200540/ /pubmed/22046162 http://dx.doi.org/10.3389/fphar.2011.00067 Text en Copyright © 2011 Antigny, Norez, Becq and Vandebrouck. http://www.frontiersin.org/licenseagreement This is an open-access article subject to a non-exclusive license between the authors and Frontiers Media SA, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and other Frontiers conditions are complied with.
spellingShingle Pharmacology
Antigny, Fabrice
Norez, Caroline
Becq, Frédéric
Vandebrouck, Clarisse
CFTR and Ca(2+) Signaling in Cystic Fibrosis
title CFTR and Ca(2+) Signaling in Cystic Fibrosis
title_full CFTR and Ca(2+) Signaling in Cystic Fibrosis
title_fullStr CFTR and Ca(2+) Signaling in Cystic Fibrosis
title_full_unstemmed CFTR and Ca(2+) Signaling in Cystic Fibrosis
title_short CFTR and Ca(2+) Signaling in Cystic Fibrosis
title_sort cftr and ca(2+) signaling in cystic fibrosis
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3200540/
https://www.ncbi.nlm.nih.gov/pubmed/22046162
http://dx.doi.org/10.3389/fphar.2011.00067
work_keys_str_mv AT antignyfabrice cftrandca2signalingincysticfibrosis
AT norezcaroline cftrandca2signalingincysticfibrosis
AT becqfrederic cftrandca2signalingincysticfibrosis
AT vandebrouckclarisse cftrandca2signalingincysticfibrosis